78 related articles for article (PubMed ID: 12371152)
1. The role of CD44 in the development and prognosis of head and neck squamous cell carcinomas.
Assimakopoulos D; Kolettas E; Patrikakos G; Evangelou A
Histol Histopathol; 2002 Oct; 17(4):1269-81. PubMed ID: 12371152
[TBL] [Abstract][Full Text] [Related]
2. The effects of CD44 down-regulation on stem cell properties of head and neck cancer cell lines.
Kidwai F; Costea DE; Hutchison I; Mackenzie I
J Oral Pathol Med; 2013 Oct; 42(9):682-90. PubMed ID: 23627635
[TBL] [Abstract][Full Text] [Related]
3. Expression of CD44 splice variants in squamous epithelia and squamous cell carcinomas of the head and neck.
Herold-Mende C; Seiter S; Born AI; Patzelt E; Schupp M; Zöller J; Bosch FX; Zöller M
J Pathol; 1996 May; 179(1):66-73. PubMed ID: 8691348
[TBL] [Abstract][Full Text] [Related]
4. Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular origin.
Salmi M; Grön-Virta K; Sointu P; Grenman R; Kalimo H; Jalkanen S
J Cell Biol; 1993 Jul; 122(2):431-42. PubMed ID: 8320265
[TBL] [Abstract][Full Text] [Related]
5. Association of CD44 V3-containing isoforms with tumor cell growth, migration, matrix metalloproteinase expression, and lymph node metastasis in head and neck cancer.
Wang SJ; Wreesmann VB; Bourguignon LY
Head Neck; 2007 Jun; 29(6):550-8. PubMed ID: 17252589
[TBL] [Abstract][Full Text] [Related]
6. Detection of putative stem cell markers, CD44/CD133, in primary and lymph node metastases in head and neck squamous cell carcinomas. A preliminary immunohistochemical and in vitro study.
Mannelli G; Magnelli L; Deganello A; Busoni M; Meccariello G; Parrinello G; Gallo O
Clin Otolaryngol; 2015 Aug; 40(4):312-20. PubMed ID: 25641707
[TBL] [Abstract][Full Text] [Related]
7. DeltaNp63 isoforms regulate CD44 and keratins 4, 6, 14 and 19 in squamous cell carcinoma of head and neck.
Boldrup L; Coates PJ; Gu X; Nylander K
J Pathol; 2007 Dec; 213(4):384-91. PubMed ID: 17935121
[TBL] [Abstract][Full Text] [Related]
8. CD44-negative cells in head and neck squamous carcinoma also have stem-cell like traits.
Oh SY; Kang HJ; Kim YS; Kim H; Lim YC
Eur J Cancer; 2013 Jan; 49(1):272-80. PubMed ID: 22770891
[TBL] [Abstract][Full Text] [Related]
9. Regulation of CD44v6-containing isoforms during proliferation of normal and malignant epithelial cells.
Soukka T; Salmi M; Joensuu H; Häkkinen L; Sointu P; Koulu L; Kalimo K; Klemi P; Grénman R; Jalkanen S
Cancer Res; 1997 Jun; 57(11):2281-9. PubMed ID: 9187133
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of expression of CD44 variants in head and neck squamous cell carcinoma.
Kanke M; Fujii M; Kameyama K; Kanzaki J; Tokumaru Y; Imanishi Y; Tomita T; Matsumura Y
Jpn J Cancer Res; 2000 Apr; 91(4):410-5. PubMed ID: 10804289
[TBL] [Abstract][Full Text] [Related]
11. Spatial distribution of cancer stem cells in head and neck squamous cell carcinomas.
Hildebrand LC; Carvalho AL; Lauxen IS; Nör JE; Cerski CT; Sant'Ana Filho M
J Oral Pathol Med; 2014 Aug; 43(7):499-506. PubMed ID: 24527751
[TBL] [Abstract][Full Text] [Related]
12. Transcription and expression of CD44 variant exons by oro-pharyngeal squamous cell carcinomas.
Bloor BK; Rajarajan A; Jaafary-Haghighat K; Odell EW
Int J Oncol; 2002 Oct; 21(4):907-13. PubMed ID: 12239634
[TBL] [Abstract][Full Text] [Related]
13. Hyaluronan and the interaction between CD44 and epidermal growth factor receptor in oncogenic signaling and chemotherapy resistance in head and neck cancer.
Wang SJ; Bourguignon LY
Arch Otolaryngol Head Neck Surg; 2006 Jul; 132(7):771-8. PubMed ID: 16847188
[TBL] [Abstract][Full Text] [Related]
14. Splice variants of CD44 in human cervical cancer stage IB to IIB.
Kainz C; Kohlberger P; Sliutz G; Tempfer C; Heinzl H; Reinthaller A; Breitenecker G; Koelbl H
Gynecol Oncol; 1995 Jun; 57(3):383-7. PubMed ID: 7539775
[TBL] [Abstract][Full Text] [Related]
15. Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma.
Prince ME; Sivanandan R; Kaczorowski A; Wolf GT; Kaplan MJ; Dalerba P; Weissman IL; Clarke MF; Ailles LE
Proc Natl Acad Sci U S A; 2007 Jan; 104(3):973-8. PubMed ID: 17210912
[TBL] [Abstract][Full Text] [Related]
16. Are CD44 variant isoforms involved in human tumour progression?
Günthert U; Stauder R; Mayer B; Terpe HJ; Finke L; Friedrichs K
Cancer Surv; 1995; 24():19-42. PubMed ID: 7553660
[TBL] [Abstract][Full Text] [Related]
17. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
Nguyen VN; Mirejovský T; Melinová L; Mandys V
Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
[TBL] [Abstract][Full Text] [Related]
18. Intratumoral lymphatics are essential for the metastatic spread and prognosis in squamous cell carcinomas of the head and neck region.
Maula SM; Luukkaa M; Grénman R; Jackson D; Jalkanen S; Ristamäki R
Cancer Res; 2003 Apr; 63(8):1920-6. PubMed ID: 12702584
[TBL] [Abstract][Full Text] [Related]
19. Altered expression of CD44 isoforms in squamous-cell carcinomas and cell lines derived from them.
Hudson DL; Speight PM; Watt FM
Int J Cancer; 1996 May; 66(4):457-63. PubMed ID: 8635860
[TBL] [Abstract][Full Text] [Related]
20. Significance of site-specific prognosis of cancer stem cell marker CD44 in head and neck squamous-cell carcinoma.
Kokko LL; Hurme S; Maula SM; Alanen K; Grénman R; Kinnunen I; Ventelä S
Oral Oncol; 2011 Jun; 47(6):510-6. PubMed ID: 21514878
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
